Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04640753 · ClinicalTrials.gov registry record

Peroral Endoscopic Myotomy for the Treatment of Achalasia

A clinical trial, sponsored by Methodist Health System.

Recruiting
Registry status
200
Enrollment target

NCT04640753: Recruiting study, sponsored by Methodist Health System.

NCT04640753 is a clinical trial that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04640753 is actively recruiting participants, sponsored by Methodist Health System.

RECRUITING
Registry status
200 participants
Enrollment target

Study Summary

There will be a retrospective chart review for patients who underwent endoscopic procedures and POEM from 06/2016 - 01/2019 \& a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021

Primary Outcome

To continue and review our treatment outcomes, patient safety in cases with achalasia, we follow up after the procedure up to 180 days. Follow-up period varies from patient to patient.

Interventions

  • PROCEDURE Endoscopic procedure for achalasia

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-02-06
Est. Completion 2027-02-05
Methodist Health System

125 total trials

What NCT04640753 shows while recruiting

NCT04640753 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Endoscopic procedure for achalasia is the first listed.

NCT04640753 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04640753 about?

NCT04640753 is a clinical study titled "Peroral Endoscopic Myotomy for the Treatment of Achalasia". There will be a retrospective chart review for patients who underwent endoscopic procedures and POEM from 06/2016 - 01/2019 \& a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021

What is the current status of trial NCT04640753?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2019-02-06. Estimated completion is 2027-02-05.

What interventions are being tested in trial NCT04640753?

The interventions under investigation include: Endoscopic procedure for achalasia (PROCEDURE).

Who is sponsoring clinical trial NCT04640753?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04640753, the US trial registry maintained by the National Library of Medicine. NCT04640753 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.